Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Español
English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
MDGL
#778
Madrigal Pharmaceuticals, Inc. Common Stock
432.000
0
-0.54%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
-0.54%
Monthly Change
-14.35%
6 month change
+1.98%
Cambio anual
+1.98%
Cierres anteriores
434.360
0
Open
432.000
0
Bid
Ask
Low
432.000
0
High
432.000
0
Volumen
139
Markets
Acciones
Atención Sanitaria
MDGL
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
21.81 M
22.08 M
22.2 M
22.29 M
22.71 M
22.94 M
—
Valuation ratios
Enterprise value
4.4 B
6.71 B
7.17 B
6.56 B
10.12 B
13.16 B
37.01 B
Price to earnings ratio
-8.44
-14.09
-18.57
-23.94
-35.83
-45.32
-123.66
Price to sales ratio
59.9
36.44
22.67
12.87
13.72
13.63
62.89
Price to cash flow ratio
10.05
14.41
18.08
21.41
61.13
68.92
169.55
Price to book ratio
1.52
8.7
2.31
2.25
3.62
21.68
29.85
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.1
0.06
0.07
0.04
0.08
0.05
0.25
Return on equity %
0.14
0.08
0.1
0.06
0.18
0.1
0.44
Return on invested capital %
—
-4 924.84
—
—
—
1 405.04
—
Gross margin %
100
100
96.71
100
100
100
396.71
Operating margin %
187.06
64.84
57.79
22.18
39.68
18.56
138.21
EBITDA margin %
—
—
-60.8
—
—
—
—
Net margin %
172.04
57.51
53.36
19.87
39.75
18.24
131.22
Liquidity ratios
Quick ratio
5.93
5.9
5.58
4.78
3.26
3.77
17.4
Current ratio
5.98
6.1
5.91
5.11
3.44
4.01
18.47
Inventory turnover
—
—
0.1
—
—
—
—
Asset turnover
0.06
0.1
0.13
0.21
0.24
0.24
0.83
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0.11
0.11
0.12
0.12
0.25
0.27
0.75
Long term debt to total equity ratio
0.15
0.16
0.17
0.17
0.54
0.56
1.44
Per share metrics
Operating cash flow per share
3.08
4.91
4.02
2.12
-3.55
5.95
8.54
EBIT per share
—
—
-3.79
—
—
—
—
EBITDA per share
—
—
-3.78
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
46.15
43.78
38.39
36.12
49.58
43.84
167.93
Net current asset value per share
48.91
48.56
44.72
45.18
59.9
55.53
205.33
Tangible book value per share
35.52
35.24
31.96
31.14
27.5
26.54
117.13
Working capital per share
40.73
40.6
37.15
36.33
42.49
41.7
157.67
Book value per share
35.74
35.46
32.17
31.34
27.83
26.86
118.21
Noticias
Madrigal: The Easiest Money May Have Been Made (NASDAQ:MDGL)
Novo Nordisk Stock: Why Wegovy Growth Beats Wall Street Expectations (NYSE:NVO)
H.C. Wainwright reitera calificación de compra para Madrigal Pharmaceuticals
H.C. Wainwright reitera calificación de compra en Madrigal Pharmaceuticals
H.C. Wainwright reiterates Madrigal Pharmaceuticals stock rating at buy
Madrigal Q4 Earnings Miss, MASH Drug Sales Drive Top Line, Stock Down
Lam Research, Goldman Sachs among market cap stock movers on Thursday
Madrigal Pharmaceuticals, Inc. (MDGL) Q4 2025 Earnings Call Transcript
Oracle, Deere among market cap stock movers on Thursday
Madrigal Q4 2025 slides: Rezdiffra nears $1B in first year sales despite EPS miss
Madrigal (MDGL) Reports Q4 Loss, Beats Revenue Estimates
Las acciones de Madrigal Pharma caen más del 5% por pérdidas del cuarto trimestre